Australia markets closed

Globus Medical, Inc. (GMED)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
51.44+0.17 (+0.33%)
At close: 04:00PM EDT
51.44 0.00 (0.00%)
After hours: 05:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.96B
Enterprise value 6.97B
Trailing P/E 48.07
Forward P/E 19.16
PEG ratio (5-yr expected) 1.74
Price/sales (ttm)3.76
Price/book (mrq)1.74
Enterprise value/revenue 4.44
Enterprise value/EBITDA 20.10

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3-10.59%
S&P500 52-week change 322.64%
52-week high 362.88
52-week low 343.39
50-day moving average 353.07
200-day moving average 352.58

Share statistics

Avg vol (3-month) 31.04M
Avg vol (10-day) 3927.77k
Shares outstanding 5112.94M
Implied shares outstanding 6135.37M
Float 8111.92M
% held by insiders 10.79%
% held by institutions 197.35%
Shares short (15 Apr 2024) 47.51M
Short ratio (15 Apr 2024) 47.36
Short % of float (15 Apr 2024) 46.70%
Short % of shares outstanding (15 Apr 2024) 45.55%
Shares short (prior month 15 Mar 2024) 45.86M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 7.83%
Operating margin (ttm)12.74%

Management effectiveness

Return on assets (ttm)4.77%
Return on equity (ttm)4.21%

Income statement

Revenue (ttm)1.57B
Revenue per share (ttm)13.87
Quarterly revenue growth (yoy)124.60%
Gross profit (ttm)N/A
EBITDA 418.24M
Net income avi to common (ttm)122.87M
Diluted EPS (ttm)1.07
Quarterly earnings growth (yoy)-70.00%

Balance sheet

Total cash (mrq)517.79M
Total cash per share (mrq)3.83
Total debt (mrq)521.22M
Total debt/equity (mrq)13.04%
Current ratio (mrq)4.88
Book value per share (mrq)29.32

Cash flow statement

Operating cash flow (ttm)243.5M
Levered free cash flow (ttm)-346.92M